Bravecto Canine Topical

Bravecto Canine Topical
4.4-9.9 lbs, 12 weeks - 1 tube
9.9-22 lbs, 12 weeks - 1 tube
22-44 lbs, 12 weeks - 1 tube
44-88 lbs, 12 weeks - 1 tube
88-123 lbs, 12 weeks - 1 tube
SKU : 581010_-RX
Price: $49.00

Veterinarian Prescription (RX) Required
  • Provides dogs up to 12 weeks of flea and tick protection in just 1 dose
*Manufacturer restricts additional discounts on this item unless explicitly specified
RX required for this item. 
Click here for our full Prescription Policy and Form

by Merck Animal Health

Bravecto (Fluralaner) is a Topical Solution for Dogs that kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick), Dermacentor variabilis (American dog tick), and Rhipicephalus sanguineus (brown dog tick)] for 12 weeks. Bravecto is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for 8 weeks.

Why use Bravecto Topical Solution for Dogs?
  • Provides flea and tick treatment for up to 12 weeks (8 weeks for the lone star tick) in just 1 dose
  • Treatment may begin at any time of the year and can continue year round without interruption
  • Bathing or water immersion 3 days after administration will not reduce the effectiveness of Bravecto against fleas and Ixodes ricinus ticks
  • Longest-lasting protection available in a topical solution
  • Available by veterinary prescription only
In well-controlled laboratory studies, Bravecto killed fleas and reduced the numbers of live fleas on dogs
by >99% and 100% within 24 and 48 hours, respectively, post-infestation for 12 weeks. In well-controlled
laboratory studies, Bravecto demonstrated ≥93.3% effectiveness against Dermacentor variabilis, Ixodes
scapularis and Rhipicephalus sanguineus 48 hours post-infestation for 12 weeks. Bravecto demonstrated
≥90% effectiveness against Amblyomma americanum 72 hours post-infestation for 8 weeks, but failed to
demonstrate ≥90% effectiveness beyond 8 weeks.

In a well-controlled U.S. field study, a single dose of Bravecto reduced fleas by ≥99.8% for 12 weeks. Dogs
with signs of flea allergy dermatitis showed improvement in erythema, alopecia, papules, scales, crusts, and
excoriation as a direct result of eliminating flea infestations.

In a European laboratory study, Bravecto demonstrated ≥98.2% effectiveness against fleas and Ixodes
ricinus ticks after multiple water immersion or shampooing occasions, the first occurring 3 days after
application, for 12 weeks.

Dosage and Administration:
Bravecto should be administered topically as a single dose every 12 weeks according to the Dosage
Schedule below to provide a minimum dose of 11.4 mg/lb (25 mg/kg) body weight.
Bravecto may be administered every 8 weeks in case of potential exposure to Amblyomma americanum
ticks (see Effectiveness).

Contraindications: There are no known contraindications for the use of the product.

Dosage Schedule 
Body Weight Ranges (lb) 
Fluralaner Content (mg)/tube 
Tubes Administered 
 4.4 – 9.9  112.5  One
 >9.9 – 22.0  250  One
 >22.0 – 44.0  500  One
 >44.0 – 88.0  1000  One
 >88.0 – 123.0*  1400  One
*dogs over 123.0 lbs should be administered the appropriate combination of tubes.

Storage Information:
Do not store above 77°F (25°C). Store in the original package in order to protect from moisture. The pouch
should only be opened immediately prior to use.

Active ingredient(s): Fluralaner

What is Bravecto Topical Solution for Dogs? Bravecto (Fluralaner) is a Topical Spot On Solution indicated for the treatment and prevention of flea and tick infestations in dogs for up to 12 weeks.

Who is Bravecto Topical Solution for Dogs for? For Dogs and Puppies 6 months of age and older weighing 4.4 pounds or greater

How does Bravecto Topical Solution for Dogs work? Fluralaner is for systemic use and belongs to the class of isoxazoline-substituted benzamide derivatives. Fluralaner is an inhibitor of the arthropod nervous system. The mode of action of fluralaner is the antagonism of the ligand-gated chloride channels (gamma-aminobutyric acid (GABA)-receptor and glutamate-receptor).

Customer Reviews
# of Ratings: 0